INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy—a Randomised Intervention Trial with losartan)

Early pharmacological interventions on transgenic models of hypertrophic cardiomyopathy (HCM) using angiotensin receptor blockers (ARBs) may be effective in preventing development of clinical phenotype or causing phenotype regression in early stages of disease. In the clinical setting, however, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivotto, Iacopo, Ashley, Euan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2015
Materias:
Lessons from the Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374100/
https://www.ncbi.nlm.nih.gov/pubmed/25830151
http://dx.doi.org/10.5339/gcsp.2015.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374100/
https://www.ncbi.nlm.nih.gov/pubmed/25830151
http://dx.doi.org/10.5339/gcsp.2015.7

Ejemplares similares